Acadia Pharmaceuticals Inc. planned insider sales
In the twelve months since 11 October 2025 insiders at Acadia Pharmaceuticals Inc. filed 4 Form 144 notices of planned sales, 52,671 shares worth $1.2 million at the time of filing, from 4 sellers. The latest, filed 5 August 2026: Schneyer Mark C. (officer), 5,849 shares worth $158,800, planned for around 5 August 2026 through Piper Sandler & Co Inc.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|
| 5 August 2026 | Schneyer Mark C. | Officer | 5,849 | $158,800 | 5 August 2026 | Piper Sandler & Co Inc | Stock Option Exercise | Form 144 |
| 26 June 2026 | Kihara James | Officer | 11,421 | $297,000 | 26 June 2026 | Piper Sandler & Co Inc | Compensation | Form 144 |
| 26 May 2026 | James K Kihara | Officer | 5,401 | $114,394 | 26 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Employee Stock Purchase Plan; Performance Shares | Form 144 |
| 10 November 2025 | James M Daly | Director | 30,000 | $670,983 | 10 November 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read more
Value is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.Source
Form 144 filings on EDGAR for Acadia Pharmaceuticals Inc.: the company's filing index, each notice read from its own XML.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.